MAXHEALTH
Max Healthcare Institute Limited (MAXHEALTH) Stock Analysis
Max Healthcare Institute Limited operates a chain of multi-specialty hospitals and clinics in India under the Max brand, offering tertiary care services. It earns from inpatient, outpatient, and international patient services. Growth comes from bed additions and occupancy improvements. It is listed on Indian stock exchanges.
Healthcare › Medical Care Facilities
₹1,000.10
-6.23% 1W | -8.80% 52W
Market Cap
97.3k CR
P/E Ratio
67.1
52W High
₹1221.9
52W Low
₹903
Div. Yield
0.2%
Beta
0.1
50 DMA
₹1042.6
200 DMA
₹1032.1
Profit Margin
16.7%
Inst. Own.
62.1%
🔥 APPROACHING RESISTANCE
🔥 APPROACHING RESISTANCE
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,285 | 1,363 | 1,335 | 1,423 | 1,543 | 1,707 | 1,868 | 1,910 | 2,028 | 2,135 | 2,068 | 2,143 | 2,366 |
| Expenses | 948 | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,369 | 1,398 | 1,505 | 1,560 | 1,529 | 1,536 | 1,768 |
| Operating Profit | 337 | 387 | 386 | 382 | 387 | 451 | 499 | 512 | 523 | 575 | 538 | 606 | 598 |
| OPM % | 26% | 28% | 29% | 27% | 25% | 26% | 27% | 27% | 26% | 27% | 26% | 28% | 25% |
| Other Income | 41 | 45 | 46 | 45 | 35 | 41 | -40 | 47 | 37 | 33 | -3 | 48 | 41 |
| Interest | 19 | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 | 54 | 60 | 67 | 71 |
| Depreciation | 56 | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 | 108 | 111 | 123 | 132 |
| Profit before tax | 303 | 366 | 360 | 336 | 321 | 374 | 309 | 402 | 400 | 446 | 365 | 465 | 436 |
| Tax % | 21% | 24% | 20% | 25% | 26% | 25% | 23% | 21% | 23% | -10% | 17% | 26% | 26% |
| Net Profit | 240 | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 | 491 | 301 | 342 | 323 |
| EPS in Rs | 2.47 | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 | 5.05 | 3.09 | 3.52 | 3.32 |
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,608 | 1,729 | 1,691 | 1,059 | 2,508 | 3,937 | 4,563 | 5,406 | 7,028 | 8,373 | 8,712 |
| Expenses | 1,467 | 1,616 | 1,535 | 965 | 2,101 | 2,986 | 3,322 | 3,913 | 5,180 | 6,131 | 6,394 |
| Operating Profit | 141 | 113 | 156 | 94 | 407 | 951 | 1,241 | 1,493 | 1,849 | 2,243 | 2,318 |
| OPM % | 9% | 7% | 9% | 9% | 16% | 24% | 27% | 28% | 26% | 27% | 27% |
| Other Income | 59 | 65 | 56 | 48 | -122 | 110 | 139 | 177 | 82 | 114 | 118 |
| Interest | 100 | 99 | 101 | 83 | 179 | 101 | 84 | 60 | 165 | 235 | 251 |
| Depreciation | 96 | 94 | 103 | 46 | 174 | 221 | 232 | 245 | 359 | 447 | 474 |
| Profit before tax | 5 | -15 | 8 | 13 | -69 | 739 | 1,064 | 1,365 | 1,406 | 1,676 | 1,711 |
| Tax % | -236% | 65% | 102% | -1% | 67% | 18% | -4% | 23% | 24% | 14% | |
| Net Profit | 16 | -25 | -0 | 59 | -138 | 605 | 1,104 | 1,058 | 1,076 | 1,442 | 1,457 |
| EPS in Rs | 0.29 | -0.47 | -0.06 | 1.10 | -1.42 | 6.24 | 11.37 | 10.88 | 11.07 | 14.82 | 14.98 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 14% | 14% | 13% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 22.0% | 27.0% | – |
| Profit CAGR | 10.0% | 60.0% | – |
Shareholding Pattern
Promoters23.74%
FIIs54.76%
DIIs17.41%
Public4.09%
Promoters23.74%
FIIs51.80%
DIIs20.03%
Public4.43%
Promoters23.72%
FIIs50.55%
DIIs21.20%
Public4.52%
Promoters23.71%
FIIs45.39%
DIIs26.32%
Public4.58%
Promoters23.71%
FIIs41.78%
DIIs29.95%
Public4.55%
Promoters23.77%
FIIs51.96%
DIIs19.36%
Public4.92%
Promoters23.75%
FIIs57.33%
DIIs14.96%
Public3.97%
Promoters23.74%
FIIs54.74%
DIIs17.59%
Public3.94%
Promoters23.71%
FIIs45.39%
DIIs26.32%
Public4.58%
Promoters23.71%
FIIs41.78%
DIIs29.95%
Public4.55%
MAXHEALTH
Holdings Analysis
Key strengths & risk signals
62
Overall
72
Fundamental
52
Technical
Risks (4)
OVERVALUED! PEG of 7.22 means expensive relative to growth rate.
WEAK POSITION! Current price (1000.1) is below both moving averages.
NEGATIVE MOMENTUM! Price declined across timeframes - down 6.2% (1 week), 1.4% (1 month), 11.4% (3 months).
WEAK YEAR! Stock declined 8.8% in the last year.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (1042.6) is above 200-day average (1032.1) - positive signal.
LOW VOLATILITY! Beta of 0.10 - stable stock, less market risk.
APPROACHING OVERSOLD! RSI at 39.7 - watch for reversal.
Fundamental & Technical Analysis
62Overall
72Fundamental
52Technical
Fundamental Breakdown
Growth Quality
23/30
Revenue CAGR: 22.4% (EXCELLENT, 15/15). Profit CAGR: 9.3% (MODERATE, 8/15).
Profit Margin
6/10
GOOD EFFICIENCY! 16.7% profit margin - above average profitability.
PEG Valuation
0/10
OVERVALUED! PEG of 7.22 means expensive relative to growth rate.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.2% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 4.45% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
10/10
BULLISH TREND! 50-day average (1042.6) is above 200-day average (1032.1) - positive signal.
Price Position
2/10
WEAK POSITION! Current price (1000.1) is below both moving averages.
Trend Pattern
10/20
AT RESISTANCE! Stock is at key resistance level.
52W Performance
3/10
WEAK YEAR! Stock declined 8.8% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 1,903,981 vs down days: 2,240,168. Ratio: 0.85x
RSI
4/5
APPROACHING OVERSOLD! RSI at 39.7 - watch for reversal.
52W Range
2/5
LOWER HALF! Trading at 30.4% of 52W range - weakness visible.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 6.2% (1 week), 1.4% (1 month), 11.4% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.10 - stable stock, less market risk.
MAXHEALTH
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-05 | Concall PDF | |
| Q4FY262026-05-29 | Concall PDF | |
| Q3FY262026-02-12 | Concall PDF | |
| Q2FY262025-11-21 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MAXHEALTH | ₹1,000.10 | 67.1 | 16.7% | 22.4% | 9.3% | -8.8% | 62 | APPROACHING RESISTANCE | +4.9% | -5.6% | +16.7% | +10.4% |
| APOLLOHOSP | ₹8,860.00 | 61.1 | 7.9% | 14.8% | 33.3% | +19.4% | 74 | APPROACHING RESISTANCE | +34.2% | +9.7% | +20.6% | +6.6% |
| ASTERDM | ₹747.40 | 121.5 | 6.5% | 15.7% | -3.0% | +21.8% | 61 | APPROACHING SUPPORT | -81.2% | -88.5% | +21.6% | +10.9% |
| FORTIS | ₹830.80 | 59.7 | 11.0% | 13.3% | 21.0% | -13.7% | 60 | BREAKDOWN | +2.3% | +0.2% | +17.5% | +7.6% |
| MEDANTA | ₹1,433.40 | 69.4 | 11.9% | 17.2% | 19.5% | +13.8% | 71 | BREAKDOWN | -0.2% | +10.2% | +26.5% | +12.5% |
| NH | ₹1,820.10 | 45.1 | 9.0% | 20.5% | 9.9% | +5.0% | 66 | APPROACHING RESISTANCE | +5.3% | -7.5% | +78.0% | +3.5% |
| KIMS | ₹766.50 | 148.8 | 4.8% | 21.3% | -10.5% | +11.3% | 60 | CONSOLIDATING DOWN | -47.2% | -2.4% | +35.3% | +9.8% |
| RAINBOW | ₹1,372.60 | 48.7 | 15.7% | 13.1% | 9.7% | +2.5% | 64 | BREAKDOWN | +13.3% | -21.3% | +33.2% | +2.2% |
Data from TradeAlone · Updated daily
MAXHEALTH News
Max Healthcare Institute Limited Inaugurates New 400 Beds Tower at Max Smart Super Speciality Hospital, Saket2026-09-03Max Healthcare Institute Ltd Q1 FY27: Revenue Rises 16% Yoy, Network Expands2026-08-13Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) moves up 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited (MAXHEALTH) gains 5% intraday2026-06-18Max Healthcare Institute Limited Q4 FY26: Revenue Rises 10% Yoy, Network Operating Ebitda Up 8%2026-05-21
